Health Risks in Children Conceived from Frozen Embryos
Children conceived from frozen embryos face increased risks of being large for gestational age (LGA), macrosomia, and higher birth weight, with additional maternal risks including hypertensive disorders of pregnancy and postpartum hemorrhage—particularly when programmed (hormone replacement) cycles are used rather than natural ovulatory cycles.
Key Perinatal Risks
Increased Birth Weight and Size
- Large for gestational age (LGA) occurs in approximately 30% of frozen embryo transfer (FET) pregnancies compared to 25% in fresh transfers 1, 2
- Birth weight is elevated by an average of 127 grams in FET singletons 3
- Macrosomia risk is significantly increased, particularly in programmed cycles (adjusted OR 1.62) 4
The mechanism appears related to the absence of corpus luteum in programmed cycles rather than cryopreservation itself, as natural cycle FET shows outcomes similar to fresh transfers 5.
Maternal Complications
Mothers carrying frozen embryo pregnancies face:
- Hypertensive disorders of pregnancy (OR 2.15) 3
- Postpartum hemorrhage (OR 2.63 in programmed cycles) 4
- Placenta accreta spectrum disorders (increased in hormone replacement cycles) 5
Critical distinction: These risks are substantially higher with programmed/hormone replacement cycles compared to natural ovulatory cycle FET 4, 5. When corpus luteum is present (natural or stimulated cycles), outcomes approximate those of fresh transfers.
Epigenetic and Long-Term Concerns
Imprinting Disorders
There is evidence of increased risk of rare genomic imprinting disorders including:
- Beckwith-Wiedemann syndrome
- Silver-Russell syndrome
- Prader-Willi syndrome
These conditions result from disruption of DNA methylation patterns during the cryopreservation process, as the epigenome is particularly vulnerable to cryoprotective agents 6.
Childhood Growth Patterns
- Height Z-scores are elevated in children from frozen transfers, suggesting they grow taller 2
- Body weight and BMI Z-scores show no significant differences through childhood 2
Protocol-Specific Risk Stratification
Highest Risk: Programmed (Hormone Replacement) Cycles
- Postterm birth (OR 1.59-1.98)
- Macrosomia (OR 1.40-1.62)
- Hypertensive disorders (OR 1.61-1.78)
- Postpartum hemorrhage (OR 2.63-2.87) 4
Lower Risk: Natural or Stimulated Ovulatory Cycles
Additional Risk Factor: Repeated Cryopreservation
Embryos frozen multiple times (re-vitrification) show:
- Reduced clinical pregnancy rates (27% vs 45%, OR 0.48)
- Reduced live birth rates (19% vs 38%, OR 0.35)
- Effect most pronounced in women under 35 years 7
Outcomes Without Increased Risk
Reassuringly, several outcomes show no increased risk:
- Preterm birth rates are comparable or lower than fresh transfers 3
- Low birth weight is less common with FET 3
- Congenital anomalies show no significant difference 7
- Miscarriage rates are similar between strategies 3
- OHSS risk is substantially reduced (OR 0.26) 3
Clinical Implications
When frozen embryo transfer is medically indicated:
Prioritize natural or stimulated ovulatory cycles over programmed hormone replacement protocols when feasible 4, 5
Avoid repeated cryopreservation in women under 35 years unless medically necessary 7
Counsel patients specifically about:
- 5-6% absolute increase in LGA risk
- Doubled risk of hypertensive disorders
- Potential for higher birth weight babies (average 127g increase)
- These risks are protocol-dependent, not inherent to cryopreservation
Enhanced monitoring during pregnancy for:
- Blood pressure (screen for hypertensive disorders)
- Fetal growth (ultrasound surveillance for macrosomia)
- Postpartum hemorrhage preparedness
Important caveat: The evidence suggests the endometrial preparation method matters more than cryopreservation itself. The absence of corpus luteum in programmed cycles appears to be the primary driver of adverse outcomes 4, 5. This represents a modifiable risk factor through cycle selection.